Evaluating the Possibility of Transfusion Medicine Through Crossmatching in Juvenile Galapagos Sea Lions (Zalophus wollebaeki)
IAAAM 2022
Taylor M. Gregory1*+; Maryanna Parker1; Diane Deresienski1; Daniela Alarcón-Ruales2; Juan Pablo Muñoz-Perez2,3; Jorge Torres4; Gabriela I. Gavilanes2; Gregory A. Lewbart1,2; Diego Páez-Rosas2,4
1Department of Clinical Sciences, North Carolina State University, Raleigh, NC, USA; 2Galapagos Science Center (GSC), Universidad San Francisco de Quito (USFQ) & UNC- Chapel Hill, Isla San Cristóbal, Islas Galápagos, Ecuador; 3Faculty of Science and Engineering, University of the Sunshine Coast, QLD, Australia; 4Dirección Parque Nacional Galápagos, Isla San Cristóbal, Islas Galápagos, Ecuador

Abstract

The Galapagos sea lion (Zalophus wollebaeki) is one of two endemic pinnipeds to the Galapagos archipelago. Over the past 30 years, this species had suffered a concerning decline in population and consequently listed as endangered on the IUCN red list.1 In part, this decline is due to increased risk of exposure to disease related to introduced animals (e.g., cats and dogs) and anthropogenic injuries associated with human population and tourism growth in the in the archipelago.2,3 Anthropogenic impacts (e.g., boat strikes) and infectious disease have the potential to cause life threatening anemia in Galapagos sea lions, indicating a need to evaluate the possibilities of blood transfusions in this species.4,5

A total of 26 juvenile sea lions were utilized under research permit PC-31-21. The animals were selected from the El Malecón rookery on San Cristobal Island; each animal was evaluated for health status via a physical examination. Only a few minor health abnormalities were noted including ocular trematodes (38%), lacerations and scars (11.5%), and thin body condition (3.8%). Approximately 3 mL of blood was obtained from each animal and evaluated for abnormalities with a lactometer, pack cell volume/total solids, and i-STAT chem8 cartridge. Hyperlactatemia and hypoglycemia were seen throughout the population; this was likely a spurious error due to time between sampling and evaluating the samples.

The blood from 20 of the sea lions was processed for crossmatching. Each sample was centrifuged for 10 minutes and the plasma was removed for later use. A small sample of red blood cells was removed and washed routinely. Each crossmatched performed mixed two drops of recipient plasma with one drop of diluted donor red blood cells and then incubated at 37ºC for 30 minutes. The crossmatch was then evaluated macroscopically and microscopically for agglutination and hemolysis. Each sample was crossmatched to itself and at least two unique sea lions throughout the project. A total of 100 crossmatches were performed.

Of the crossmatches performed, 77% (77/100) were negative for any reaction, 12% (12/100) had only microscopic agglutination, 4% (4/100) had hemolysis, 4% (4/100) had hemolysis and microscopic agglutination, and 3% (3/100) had a weak positive macroscopic agglutination reaction. Possible explanations for the reactions seen in this study included previous blood exposure due to intra-rookery fighting, hemolysis seen in the plasma samples prior to use, or natural blood types in this species of sea lion.6–8 Our study indicates that in an emergency situation, a transfusion between Galapagos sea lions would have a high chance of success.

Acknowledgements

All authors thank the Galapagos National Park Directorate (GNPD) for their support and assistance performing this project. Specifically, the authors acknowledge the following GNPD members for their direct role in this project: Maryuri Yepez, Gabriel Vasquez and Jefferson Herrera. The authors also acknowledge the Galapagos Science Center for use of their facilities to carry out the lab work in this study, and especially to Carlos Mena, Sofia Tacle, Ana Carrión and Jessenia Sotamba for all the facilities and assistance in the administrative component. The authors thank Kent Passingham for his help in obtaining supplies for this study. The authors would like to thank the following veterinarians from North Carolina State University for their assistance in this project: Drs. Shelly Vaden, Ashley deMey, Jamie Madigan, Ashlan Westbrook, Carl Thomas, Elsa Sanabria, Jane Kim, Kaitlin Stahl, Kristen Bagley, Khushboo Dass, Marisa Hofmeister, Nicole Freitas, Pheobe Delgado, Sophie Mercer, and Susie Jones. Finally, the authors thank the North Carolina State University College of Veterinary Medicine Clinical Pathology Laboratory for their guidance in developing a crossmatching protocol for this project.

Literature Cited

1.  Trillmich F. 2015. Zalophus wollebaeki. The IUCN Red List of Threatened Species 2015: e.T41668A45230540.

2.  Dekinger J, Gordillo L, Montero-Serra I, Murillo JC, Guevara N, Hirschfeld M, Fietz K, Rubianes F, Dan M. 2015. Urban life of Galapagos sea lions (Zalophus wollebaeki) on San Cristobal Island, Ecuador: colony trends and threats. J Sea Res. 105:10–14.

3.  Sarzosa S, Duignan P, DeRango G, Espinoza E, Loyola A, Rueda D, Ríos C, Field C, Páez- Rosas D. 2021. Occurrence of Mycoplasmas in Galapagos sea lions (Zalophus wollebaeki): and their association with other respiratory pathogens. J Wildl Dis. 57(3):623–627.

4.  Gough A. 2007. Differential diagnosis in small animal medicine. Oxford: Blackwell Publishing.

5.  Schipper J, Chanson JS, Chiozza F, Cox NA, Hoffmann M, Katariya V, Lamoreux J, Rodrigues ASL, Stuart SN, Temple HJ, Baillie J, Boitani L, Lacher TE, Mittermeier RA, Smith AT, Absolon D, Aguiar JM, Amori G, Bakkour N, Baldi R, Berridge RJ, Bielby J, Black PA, Blanc JJ, Brooks TM, Burton JA, Butynski TM, Catullo G, Chapman R, Cokeliss Z, Collen B, Conroy J, Cooke JG, da Fonseca GAB, Derocher AE, Dublin HT, Duckworth JW, Emmons L, Emslie RH, Festa-Bianchet M, Foster M, Foster S, Garshelis DL, Gates C, Gimenez-Dixon M, Gonzalez S, Gonzalez-Maya JF, Good TC, Hammerson G, Hammond PS, Happold D, Happold M, Hare J, Harris RB, Hawkins CE, Haywood M, Heaney LR, Hedges S, Helgen KM, Hilton-Taylor C, Hussain SA, Ishii N, Jefferson TA, Jenkins RKB, Johnston CH, Keith M, Kingdon J, Knox DH, Kovacs KM, Langhammer P, Leus K, Lewison R, Lichtenstein G, Lowry LF, Macavoy Z, Mace GM, Mallon DP, Masi M, McKnight MW, Medellin RA, Medici P, Mills G, Moehlman PD, Molur S, Mora A, Nowell K, Oates JF, Olech W, Oliver WRL, Opera M, Patterson BD, Perrin WF, Polidoro BA, Pollock C, Powell A, Protas Y, Racey P, Ragle J, Ramani P, Rathbun Reeves RR, Reilly SB, Reynolds JE, Rondinini C, Rosell-Ambal RG, Rulli M, Rylands AB, Savini S, Schank CJ, Sechrest W, Self-Sullivan C, Shoemaker A, Sillero-Zubiri C, De Silva N, Smith DE, Srinivasulu C, Stephenson PJ, van Strien N, Talukdar BK, Taylor BL, Timmins R, Tirira DG, Tognelli MF, Tsytsulina K, Veiga, LM, Vie JC, Williamson, EA, Wyatt SA, Xie Y, Young BE. 2008. The status of the world’s land and marine mammals: diversity, threat, and knowledge. Sci. 322(5899):225–230.

6.  Davidow EB, Blois SL, Goy-Thollot I, Harris L, Humm K, Musulin S, Nash K J, Odunayo A, Sharp CR, Spada E, Thomason J, Walton J, Wardrop KJ. 2021. Association of veterinary hematology and transfusion medicine (AVHTM) transfusion reaction small animal consensus statement (TRACS) part 2: prevention and monitoring. J Vet Emerg Crit Care. 31(2):167–188.

7.  Trillmich F, Wolf JBW. 2008. Parent-offspring and sibling conflict in Galapagos fur seal and sea lions. Behav Ecol Sociobiol. 62:363–375.

8.  Young JK, González-Suárez M, Gerber LR. 2008. Determinants of agonistic interactions in California sea lions. JSTOR. 145(12):1791–1810.

 

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Taylor M. Gregory
Department of Clinical Sciences
North Carolina State University
Raleigh, NC, USA


MAIN : Session 3: <i>In Situ</i> Health : Transfusion Medicine Possibility: Galapagos Sea Lions
Powered By VIN
SAID=27